Mia's Feed
Medical News & Research

Cancer Cells Transfer Mitochondria to Neighboring Cells to Support Tumor Growth

Cancer Cells Transfer Mitochondria to Neighboring Cells to Support Tumor Growth

Share this article

Scientists at ETH Zurich have discovered that cancer cells transfer mitochondria to neighboring healthy cells, transforming their behavior and promoting tumor growth. This novel mechanism offers potential new targets for cancer therapy.

2 min read

Research conducted at ETH Zurich has uncovered a novel mechanism by which cancer cells actively transfer their mitochondria to nearby healthy connective tissue cells, known as fibroblasts. This mitochondrial transfer enables the fibroblasts to transform into tumor-associated fibroblasts that significantly support tumor progression. The process involves tiny membrane tubes that function similarly to pneumatic systems, allowing mitochondria to be transported from cancer cells into adjacent cells.

This transfer reprograms the fibroblasts, causing them to multiply faster, produce more ATP (the cell's energy currency), and secrete elevated levels of growth factors and cytokines—all of which foster a more aggressive tumor environment. Moreover, these altered fibroblasts modify the extracellular matrix, increasing tissue components that further facilitate tumor growth.

The discovery was serendipitous, originating from observing cell connections between cancer and fibroblast cells in petri dish cultures. The research revealed that mitochondria can be exchanged bidirectionally—an insight that was previously limited to unidirectional transfer from healthy cells to damaged nerve cells after strokes. The findings suggest that tumors exploit this cellular communication for their survival and expansion.

Additionally, the study identified the protein MIRO2 as a crucial molecule mediating the transfer of mitochondria. High levels of MIRO2 were observed in cancer cells involved in mitochondrial transfer, especially at tumor edges where cells invade healthy tissue. Blocking MIRO2 in laboratory and animal models inhibited mitochondrial transfer and prevented fibroblasts from becoming tumor-promoting, indicating potential therapeutic targets.

While these results are promising, further research is needed to develop inhibitors that can effectively block MIRO2 in humans without adverse effects. If successful, such therapies could slow down or halt tumor growth by interrupting these mitochondrial exchanges. Overall, this study highlights a sophisticated method tumors use to manipulate their environment and offers new avenues for cancer treatment.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Eight Babies Successfully Born Using Mitochondrial Donation Technique to Prevent Mitochondrial DNA Diseases

New treatment using mitochondrial donation technique has successfully resulted in eight healthy births, reducing the risk of inheriting mitochondrial DNA diseases. This breakthrough offers hope for affected families and marks a significant advancement in reproductive medicine.

Long-Term Heart Disease Risks in Elderly After Hurricane Sandy

New research reveals that elderly residents in flood-affected areas after Hurricane Sandy face increased long-term risks of heart disease, highlighting the need for enhanced disaster-related healthcare policies.

FDA Approves Zynyz as First-Line Therapy for Advanced Anal Cancer

The FDA has approved Zynyz, a PD-1 inhibitor, as the first-line treatment for advanced anal cancer, offering new hope for patients with limited options and demonstrating significant clinical benefits based on recent trial results.

New White Paper Calls for Urgent Action to Address Hearing Loss in Care Homes

A new white paper highlights the urgent need for better support for residents with hearing loss in care homes, emphasizing improved care practices to enhance quality of life and safety.